Gomez R, Chen W, Houghton S. Differences between DSM-5-TR and ICD-11 revisions of attention deficit/hyperactivity disorder: A commentary on implications and opportunities. World J Psychiatry 2023; 13(5): 138-143 [PMID: 37303925 DOI: 10.5498/wjp.v13.i5.138]
Corresponding Author of This Article
Wai Chen, BMed, MPhil, MRCP, PhD, Professor, Curtin Medical School, Curtin University, 410 Koorliny Way, Perth 6102, Australia. wai.chen@curtin.edu.au
Research Domain of This Article
Psychiatry
Article-Type of This Article
Opinion Review
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Psychiatry. May 19, 2023; 13(5): 138-143 Published online May 19, 2023. doi: 10.5498/wjp.v13.i5.138
Differences between DSM-5-TR and ICD-11 revisions of attention deficit/hyperactivity disorder: A commentary on implications and opportunities
Rapson Gomez, Wai Chen, Stephen Houghton
Rapson Gomez, School of Science, Psychology, and Sport, Federation University, Melbourne 3806, Australia
Wai Chen, Curtin Medical School, Curtin University, Perth 6102, Australia
Stephen Houghton, Graduate School of Education, The University of Western Australia, Perth 6009, Australia
Author contributions: Gomez R reviewed the literature and drafted the manuscript; Chen W conceived the idea for the manuscript, reviewed the literature and revised the manuscript; Houghton S reviewed the literature and revised the manuscript.
Conflict-of-interest statement: Nil. Wai Chen served as a reviewer for the DSM-5 Clinical and Public Health Committee during the DSM-5 revision; but this role did not and has not led to any conflict of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Received: December 16, 2022 Peer-review started: December 16, 2022 First decision: February 20, 2023 Revised: March 2, 2023 Accepted: April 18, 2023 Article in press: April 18, 2023 Published online: May 19, 2023 Processing time: 154 Days and 5.4 Hours
Core Tip
Core Tip: Three major differences between DSM-5-TR and ICD-11 are: (1) The number of diagnostic criteria for inattention, hyperactivity (HY) and impulsivity (IM) symptoms; (2) the clarity and standardization of diagnostic thresholds; and (3) the partitioning of HY and IM symptoms into sub-dimensions between previous and current editions of DSM and ICD. Currently, no ICD-11 based attention deficit hyperactivity disorder (ADHD) rating scales exist. The absence of research evidence to inform and reconcile these differences represents opportunities for research. Emerging research findings suggest that 'impulsivity’ is likely the key latent factor underlying different expressions of ADHD symptoms; and the current criteria merging HY/IM could limit such explorations.
